uniteTOlove.ca

Opioid Crisis & Public Health Response — Playbook

How many people are dying of overdoses in Toronto now, and what the city's public-health response actually does about it.

DRAFTThe playbookThe evidence file

What Toronto can actually do on the opioid crisis — each move with its costs, its beneficiaries, and its receipts.

v2.0 · 2026-08-11

---

The honest bottom line

Toronto already paid for the answers here, including the uncertainties. The province's own coroner data, the province's own Superior Court, and the province's own budget documents have already measured the mortality trend, ruled on the harm at stake, and priced the replacement model. Nationally, opioid deaths fell in 2025 — 5,630 deaths, down 23% from 2024, which was itself down 17% from 2023 — and Ontario's own quarterly figures through spring 2026 show the same direction: 654 suspect drug-related deaths in the three months to May 2026, a 10% drop from the prior three months. A separately reported, narrower figure claiming confirmed and probable Ontario opioid deaths rose 19.4% from April 2025 (108) to October 2025 (129) has been checked directly against the Office of the Chief Coroner's own quarterly data and does not hold up: Ontario recorded 329 opioid toxicity deaths in Q1 2025 and 323 in Q2 2025 — essentially flat, both 25% below Q4 2024, continuing a decline the coroner's own report says began in Q3 2024. That rising figure is retracted, not merely hedged, because it contradicts the primary data for the same months; the decline was continuous through the first half of 2025, not interrupted mid-year. Toronto's own drug supply kept moving in 2026: a new adulterant, medetomidine, showed up alongside xylazine in April, the same week a five-death cluster hit the downtown-midtown corridor. Ontario's Community Care and Recovery Act (December 2024) set a 200-metre buffer keeping supervised consumption sites away from schools and daycares, banned municipalities from seeking their own decriminalization exemptions, and required the Minister of Health to personally approve any local safer-supply participation; nine sites were replaced by provincially funded HART Hubs in April 2025, and in March 2026 the province ended funding for the seven sites still standing, two of them in Toronto. A Toronto-based provider sued over it, arguing the Act violates the Charter; in March 2025 the Ontario Superior Court paused the school-proximity closures while the case proceeds, finding it foreseeable that people would die from the closures who wouldn't otherwise have died — that's the court's reasoning for keeping sites open pending trial, not a final ruling on the law itself, and no source found here confirms whether that final ruling has landed. Both sides of this argument are documented at once: $550 million is committed to 28 treatment-focused hubs with real annual operating money behind them, and Opioid Agonist Therapy has the strongest mortality-reduction evidence of any single intervention in the field generally — though neither of the backgrounder's two documented HART Hub site examples (Guelph-Wellington, Ottawa) confirms OAT is actually what those hubs are built around in practice; the sites now closing reversed almost 22,000 overdoses on-site over four years with zero deaths ever recorded inside one, and one year into the hub rollout, independent reporting found real, specific gaps against the model's own promises — no withdrawal beds and a full waitlist at one hub, a site in Ottawa offering nothing but showers and a place to sit eight months after its consumption service closed.

A non-police follow-up after every overdose reversal. (a recommendation card) Using outreach the City already funds, so a reversal doesn't end at reversal.

A Toronto-specific monthly overdose-and-adulterant dashboard. (a recommendation card) Matched to the province's own reporting speed, so the next cluster like April's gets a public warning as fast as the province already manages provincially.

Neither requires inventing a new program or picking a side in the larger argument. Both require reading what's already been measured, all the way through — including the parts that don't flatter either side. What this file doesn't settle: whether the province's closures have had any effect, positive or negative, on Ontario's opioid mortality trend — a declining trend during a policy change is not proof the policy caused the decline. It doesn't confirm the Charter challenge's final outcome, only that an injunction is currently in force. And most figures here came from search-based discovery, not a full read of the underlying court judgment or evidence brief — the litigation status is sourced but not yet independently re-verified against the primary text, while the mortality figures have now been checked directly against the coroner's own primary quarterly data.

---

a recommendation card — Non-Police Warm-Handoff Follow-Up After Every Naloxone Reversal

Card id: a recommendation card · Issue: opioid-crisis-public-health-response · Backgrounder: our research file for that page · Trust: New load-bearing findings (backgrounder NEW-2026-4, NEW-2026-8) + carried-forward (CL-487)

Problem

Ontario's supervised consumption sites documented almost 22,000 onsite overdose reversals between March 2020 and May 2024 [CL-487], and provincial coroner data separately show a bystander was present at more than 1 in 7 opioid toxicity deaths in Q4 2025, with naloxone administered in nearly 1 in 6 [NEW-2026-4] — meaning a large population of overdose-reversal events, both inside and outside formal SCS settings, currently ends at the point of reversal rather than at a warm handoff to health/social services. Independent reporting on the HART Hub model one year in documents at least two site-level examples where the treatment/recovery follow-through the model is designed to provide is not yet functioning as intended: unavailable withdrawal-management beds and fully occupied supportive housing in Guelph-Wellington, and a hub offering only showers, meals, and leisure activities eight months after the linked SCS closure in Ottawa [NEW-2026-8]. This card addresses only the gap between "a reversal occurred" and "a non-police follow-up contact happened," not SCS/HART Hub siting or funding levels generally.

Action

The City directs existing Toronto Public Health harm-reduction and outreach capacity to provide a non-police-led, peer-supported follow-up contact after every naloxone administration or SCS-linked reversal event within municipal reach — a warm handoff to same-day service navigation (health, housing, harm-reduction) rather than a reversal-and-release pattern — building on infrastructure the City already runs (Toronto Overdose Information System, existing harm-reduction outreach teams).

Jurisdiction split

Cost

Order-of-magnitude: low millions CAD annually for a peer-navigation follow-up staffing layer, anchored to the named comparator of a single HART Hub's own base operating funding of $6.3 million annually [NEW-2026-17] — this card proposes a smaller, coordination-layer cost, not a new hub-scale facility, and should be read as a fraction of that comparator rather than an equivalent spend.

Funding path

Existing Toronto Public Health harm-reduction operating budget as the base mechanism; no specific existing line-item figure for this exact function was located this review, stated as a gap rather than invented. A provincial cost-share request would logically route through the same Homelessness Prevention Program / HART Hub funding envelope the backgrounder documents [NEW-2026-17], but this card does not assert that request has already been made.

Who benefits, and how

People who use drugs and survive an overdose reversal, via a same-day connection to health/social/harm-reduction services rather than reversal-and-release; frontline paramedics and harm-reduction workers, via a defined non-police handoff pathway that does not depend on each individual site's own ad hoc capacity.

Who bears the cost, and how

City taxpayers, via the Toronto Public Health operating budget; opportunity cost of outreach-staff time redirected from other harm-reduction functions if not funded as incremental capacity — this card does not assume new money is available and flags that as a funding-path open question.

Who benefits from the status quo

Per the backing backgrounder's Cui Bono table (both rows pending formal a registered entity/a registered accountability claim registration):

This card's specific Action (non-police warm-handoff follow-up) is not asserted to directly counter either entity's documented position — both rows are carried over from the backgrounder's issue-level Cui Bono finding, not re-derived for this card specifically.

Financial ROI

Directional only: the inherited master briefing's general case that harm-reduction spending is "cheap relative to the deaths and emergency costs it prevents" (carried-forward) applies here in principle, but no source estimates a specific dollar return for a warm-handoff-following-naloxone program specifically — a plausible but unquantified case, not a modelled figure.

Economic ROI

Not yet estimable as a broad societal-growth/employment figure. The available third-party literature for this action type is cost-avoidance to the health/justice system, offered here only as directional context, not a Toronto- or program-specific Economic ROI estimate: a Canadian supervised-consumption-site cost-analysis study found each overdose managed onsite produced roughly $1,600 CAD in avoided ambulance/emergency-department costs, with over $2.3 million in cumulative savings at one facility (Harm Reduction Journal, 2022); a U.S. cost-benefit analysis separately found $7.50 in avoided hospital costs per $1 invested in community naloxone distribution (Common Good Data). Both describe the underlying overdose-response/naloxone-distribution function generally, not the specific non-police warm-handoff follow-up layer this card proposes, which is a downstream coordination service, not the reversal event itself. Confidence: low — both figures describe a different, upstream intervention, and the naloxone figure is U.S.-sourced, not Ontario/Toronto-specific.

Social ROI

Directional: reduces the population of overdose-reversal survivors who receive no follow-up contact, drawing on the documented scale of both the SCS reversal record [CL-487] and the bystander/naloxone administration data [NEW-2026-4] as evidence the addressable population is large — no source yet quantifies how many reversal events currently receive a follow-up contact today, so the "gap size" itself is not precisely known.

Environmental ROI

Genuinely neutral — a non-police peer-navigation follow-up staffing layer, built on existing outreach infrastructure (Toronto Overdose Information System, existing harm-reduction teams), has no material emissions, land-use, water, waste, or resilience footprint distinct from the existing outreach operations it extends. Confidence: high, no plausible material environmental pathway for a staffing/coordination-layer addition to an existing service.

Evidence

Confidence & uncertainties

Medium-low confidence. The scale of the addressable reversal population is well-documented; the specific claim that a non-police warm-handoff program would meaningfully close the gap is this card's own inference, not a claim independently evidenced by an outcome study in this review. All NEW-2026-#-style citations are WebSearch-discovered, not independently fetched and read in full primary-source form, and are pending formal formal registration.

Status

DRAFT — blocked on: confirming whether Toronto Public Health already runs an equivalent warm-handoff protocol that this review simply did not locate; fairness and legal review; independent primary-source verification of the NEW-2026-4/NEW-2026-8 findings.

---

a recommendation card — A Toronto-Specific Monthly Overdose-and-Adulterant Public Dashboard, Matched to the Province's Own Reporting Cadence

Card id: a recommendation card · Issue: opioid-crisis-public-health-response · Backgrounder: our research file for that page · Trust: New load-bearing findings (backgrounder NEW-2026-3) + carried-forward (CL-479, CL-480)

Problem

Ontario's own provincial coroner data are published on a documented monthly/quarterly cadence with granular figures (217 deaths in May 2026 alone; a 654-death three-month rolling total; explicit period-over-period percentage comparisons) [NEW-2026-3]. This page’s inherited findings show Toronto-specific events that would benefit from equally fast public surfacing — a new adulterant (medetomidine) identified in April 2026 alongside a documented five-death cluster in the same week [CL-479], and compounding-adulteration patterns in carfentanil samples collected over a multi-year window [CL-480] — but this review did not confirm that Toronto Public Health's own Toronto Overdose Information System and Annual Summary of Opioid Toxicity Deaths (both tier-1 atlas sources) are published on a comparably fast, comparably granular cadence, or that adulterant-specific findings from the Toronto Drug Checking Service are cross-referenced against Toronto-specific mortality figures in one public place. This card addresses only that data-cadence and cross-referencing gap, not SCS/HART Hub policy.

Action

The City commits Toronto Public Health to a standing monthly public update of the Toronto Overdose Information System, explicitly cross-referencing the same month's Toronto Drug Checking Service adulterant findings — matching, in cadence and granularity, the provincial ODPRN/Office of the Chief Coroner reporting rhythm this review found to already exist provincially [NEW-2026-3].

Jurisdiction split

Cost

Order-of-magnitude: low — a data-publication cadence change using systems the City already operates, anchored to the named comparator of the province's own existing ODPRN/Office of the Chief Coroner monthly reporting series [NEW-2026-3], which already demonstrates this cadence is operationally achievable at comparable or larger geographic scale without a new program being built from scratch.

Funding path

Existing Toronto Public Health surveillance operating budget, which already funds the Toronto Overdose Information System and Toronto Drug Checking Service as ongoing programs; this card asks for a cadence and integration change within that existing envelope, not a new funding source.

Who benefits, and how

People who use drugs and frontline harm-reduction workers city-wide, via faster public awareness of adulterant changes and death clusters of the kind documented in April 2026 [CL-479]; City policymakers and Council, via a Toronto-specific evidence base that would sit alongside the province-wide mortality decline already corroborated by the coroner's own quarterly data [NEW-2026-1, NEW-2026-3]. A previously cited "unreconciled tension" with a separately reported mid-2025 mortality increase was checked live this review and retracted — the increase figure did not hold up against the coroner's own totals — so this card's case for faster local reporting now rests on the value of Toronto-specific granularity itself, not on resolving a tension that no longer exists.

Who bears the cost, and how

City taxpayers, via the existing Toronto Public Health operating budget; no new payer class identified, since this reallocates publication cadence and cross-referencing effort rather than building new data-collection infrastructure.

Who benefits from the status quo

Per the backing backgrounder's Cui Bono table (both rows pending formal a registered entity/a registered accountability claim registration — same finding as a recommendation card above):

This card's specific Action (a faster public dashboard) is not asserted to directly counter either entity's documented position — both rows are carried over from the backgrounder's issue-level Cui Bono finding, not re-derived for this card specifically.

Financial ROI

Not separately estimated — this is a reporting/transparency change, not a program with a direct fiscal-offset case in the sources reviewed.

Economic ROI

Not yet estimable. This is a data-publication cadence change, not a program with a modelled societal-growth or employment effect; a search for a public-health-surveillance-dashboard economic-impact study did not surface a figure specific to this action type. A systematic review of public-health surveillance-system economic evaluations exists in the literature (European Journal of Public Health) but was not accessed in full this review, flagged as a lead for a future pass rather than a comparator used here. Confidence: low — a genuine gap; the existence of a relevant literature category was located, but no specific, readable figure was confirmed, so none is cited as a range.

Social ROI

Directional: faster, cross-referenced public alerting is a plausible mitigant against the specific failure mode this page’s inherited findings document — a new adulterant and a death cluster occurring in the same short window [CL-479] — though no source quantifies how much faster alerting would need to be to change outcomes, so this is stated as directional, not modelled.

Environmental ROI

Genuinely neutral — a monthly public-reporting cadence change using existing data systems (Toronto Overdose Information System, Toronto Drug Checking Service) has no material emissions, land-use, water, waste, or resilience footprint. Confidence: high, no plausible environmental pathway for a data-reporting cadence change.

Evidence

Confidence & uncertainties

Medium confidence that the provincial reporting cadence comparator is real and achievable at scale; low-medium confidence on whether Toronto Public Health's existing systems already do some version of this and this review simply did not locate it — flagged explicitly as a possibility rather than assumed away. All NEW-2026-#-style citations are WebSearch-discovered and pending independent primary-source verification and formal formal registration.

Status

DRAFT — blocked on: confirming current Toronto Overdose Information System publication cadence directly (this review did not fetch the live dashboard); fairness and legal review.

---

Production record

Drafting record

Version: v1.1 (cards content, tightened into v2.0 playbook shape 2026-08-11) · Original date: 2026-07-13 · Status: DRAFT · · Backgrounder: our research file for that page. Written per this library's standard page structure. Every factual premise traces to a formally registered claim, a fact cited directly to the inherited master briefing (drug harm reduction) (tagged carried-forward), or a NEW-2026-#-style source quote in the backgrounder. Per the costing bar (Q-06), all costs are order-of-magnitude ranges anchored to named comparators, never fake-precise line items. Per this page’s binding rules, this document states facts and jurisdiction, and does not adjudicate harm-reduction-vs-enforcement-first framing; both cards are scoped to actions within or adjacent to existing municipal authority, not to the province's own SCS/HART Hub siting decisions, which this page’s backgrounder documents but does not take a position on. Author voice: The Unknown Soldier.

v2.0 restructure (2026-08-11, a recorded standing decision/PLAYBOOK conversion, Lane L3b): opened with "The honest bottom line," adapted from archive/dayone/opioid-crisis-public-health-response.md (retired day-one memo, a recorded standing decision); each card tightened, verbose ROI Range/Comparator-source/Confidence blocks collapsed into flowing one-line-per-dimension prose; per-card header lines condensed (redundant "File:" field dropped); all citation tokens (CL-479, CL-480, CL-487, NEW-2026-1, NEW-2026-3, NEW-2026-4, NEW-2026-8, NEW-2026-11 [retracted, kept for the record], NEW-2026-12, NEW-2026-17, carried-forward, New load-bearing findings) preserved verbatim.

About this file